Walleye Trading LLC Viking Therapeutics, Inc. Put Options Transaction History

Walleye Trading LLC

12 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$47.39 - $80.2 $94,780 - $160,400	-2,000 Reduced 50.0%	2,000 $106,000
Q1 2024 May 15, 2024	SELL	$17.4 - $94.5 $372,359 - $2.02 Million	-21,400 Reduced 84.25%	4,000 $328,000
Q4 2023 Feb 14, 2024	BUY	$9.24 - $19.64 $170,940 - $363,340	18,500 Added 268.12%	25,400 $472,000
Q3 2023 Nov 14, 2023	BUY	$10.92 - $16.0 $10,920 - $16,000	1,000 Added 16.95%	6,900 $76,000
Q2 2023 Aug 14, 2023	BUY	$14.84 - $24.79 $26,712 - $44,622	1,800 Added 43.9%	5,900 $95,000
Q1 2023 May 15, 2023	SELL	$8.08 - $17.33 $65,448 - $140,373	-8,100 Reduced 66.39%	4,100 $68,000
Q4 2022 Feb 14, 2023	BUY	$2.72 - $9.4 $33,184 - $114,680	12,200 New	12,200 $114,000
Q4 2019 Feb 14, 2020	BUY	$6.38 - $8.73 $12,122 - $16,587	1,900 New	1,900 $15,000
Q3 2019 Nov 14, 2019	SELL	$6.55 - $8.6 $3,275 - $4,300	-500 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$7.67 - $10.63 $1,534 - $2,126	-200 Reduced 28.57%	500 $4,000
Q1 2019 May 15, 2019	SELL	$7.58 - $9.94 $183,436 - $240,548	-24,200 Reduced 97.19%	700 $7,000
Q4 2018 Feb 14, 2019	BUY	$7.16 - $16.21 $178,284 - $403,629	24,900 New	24,900 $190,000

480

66.2M

6.24M

3.01M

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $5.25B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.